Morbidity and Outcomes Following Axillary Lymphadenectomy for Melanoma: Weighing the Risk of Surgery in the Era of MSLT-II
Crossref DOI link: https://doi.org/10.1245/s10434-017-6242-3
Published Online: 2017-11-20
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Postlewait, Lauren M.
Farley, Clara R.
Seamens, Alexandra M.
Le, Nina
Rizzo, Monica
Russell, Maria C.
Lowe, Michael C.
Delman, Keith A.
Funding for this research was provided by:
Katz Foundation
License valid from 2017-11-20